Relationship between hippocampal volume and treatment response before and after escitalopram administration in patients with depression

The hippocampus plays a crucial role in memory formation and emotional regulation, and is closely related to the pathology of depression. Escitalopram, a selective serotonin reuptake inhibitor, promotes neurogenesis in the dentate gyrus of the hippocampus and alters its structure. This study examined the relationship between these escitalopram-induced structural changes and treatment response in 107 patients with moderate to severe depression, of whom 56 were female (52.3%), with a mean age of 41.5 years (range: 25-73 years). Follow-up data were available for 71 patients (66.4%). Changes in the volume and laterality of hippocampal subregions were compared before and after escitalopram treatment between Responders to escitalopram (n = 53) and Nonresponders (n = 54). The results indicated that Responders had a larger left hippocampal volume (β = 189.3, 95% CI [71.4, 307.2], Cohen's f² ≈ 0.094) and greater leftward laterality (β = 0.012, 95% CI [2.2 × 10⁻⁴, 0.024], Cohen's f² ≈ 0.04) than Nonresponders at baseline. Additionally, the right hippocampus and right hippocampal head exhibited increased volume (β = 80.6, 95% CI [28.5, 132.8], Cohen's f² ≈ 0.005; β = 50.4, 95% CI [22.2, 78.5], Cohen's f² ≈ 0.006) and altered laterality (β = -0.011, 95% CI [-0.022, -4.1 × 10⁻⁴], Cohen's f² ≈ 0.003; β = -3.3 × 10⁻⁴, 95% CI [-5.7 × 10⁻⁴, -8.3 × 10⁻⁵], Cohen's f² ≈ 0.006) in response to escitalopram in Responders compared to Nonresponders. Furthermore, the volume changes in the right hippocampus and right hippocampal head correlated with core depressive symptoms. It is suggested that these volume changes play an important role in the improvement of core symptoms of depression by escitalopram treatment. These findings can help to reveal the mechanisms of action of selective serotonin reuptake inhibitors and have the potential to facilitate the early identification of patients who will respond to treatment.

Authors

Institutions

Publication Details

Journal
Translational Psychiatry
Published
2025-12-30
DOI
https://doi.org/10.1038/s41398-025-03796-4
Primary Topic
Memory and Neural Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relationship between hippocampal volume and treatment response before and after escitalopram administration in patients with depression

Eri Itai, Tatsuji Tamura, Toshiharu Kamishikiryo, Yuki Mitsuyama et al.
Translational Psychiatry
Memory and Neural Mechanisms
article

Relationship between hippocampal volume and treatment response before and after escitalopram administration in patients with depression

Eri Itai, Tatsuji Tamura, Toshiharu Kamishikiryo, Yuki Mitsuyama, Hiroaki Jitsuiki, Akio Mantani, Yoshikazu masuda, Norio yokota, Osamu yamamoto, Go okada
article en

Abstract

The hippocampus plays a crucial role in memory formation and emotional regulation, and is closely related to the pathology of depression. Escitalopram, a selective serotonin reuptake inhibitor, promotes neurogenesis in the dentate gyrus of the hippocampus and alters its structure. This study examined the relationship between these escitalopram-induced structural changes and treatment response in 107 patients with moderate to severe depression, of whom 56 were female (52.3%), with a mean age of 41.5 years (range: 25-73 years). Follow-up data were available for 71 patients (66.4%). Changes in the volume and laterality of hippocampal subregions were compared before and after escitalopram treatment between Responders to escitalopram (n = 53) and Nonresponders (n = 54). The results indicated that Responders had a larger left hippocampal volume (β = 189.3, 95% CI [71.4, 307.2], Cohen's f² ≈ 0.094) and greater leftward laterality (β = 0.012, 95% CI [2.2 × 10⁻⁴, 0.024], Cohen's f² ≈ 0.04) than Nonresponders at baseline. Additionally, the right hippocampus and right hippocampal head exhibited increased volume (β = 80.6, 95% CI [28.5, 132.8], Cohen's f² ≈ 0.005; β = 50.4, 95% CI [22.2, 78.5], Cohen's f² ≈ 0.006) and altered laterality (β = -0.011, 95% CI [-0.022, -4.1 × 10⁻⁴], Cohen's f² ≈ 0.003; β = -3.3 × 10⁻⁴, 95% CI [-5.7 × 10⁻⁴, -8.3 × 10⁻⁵], Cohen's f² ≈ 0.006) in response to escitalopram in Responders compared to Nonresponders. Furthermore, the volume changes in the right hippocampus and right hippocampal head correlated with core depressive symptoms. It is suggested that these volume changes play an important role in the improvement of core symptoms of depression by escitalopram treatment. These findings can help to reveal the mechanisms of action of selective serotonin reuptake inhibitors and have the potential to facilitate the early identification of patients who will respond to treatment.

Translational PsychiatryVol. 16(1)
Hiroshima University (JP)
Japan Agency for Medical Research and Development
Good health and well-being
Openalex Percentile: Top 31%
Memory and Neural Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.